Sign up for the free MyBolton newsletter to get the top stories direct to your inbox A new jab to fight Covid-19 variants is currently being trialled in Manchester.
It is hoped that the new vaccine could offer longer-lasting immunity than currently available vaccines. The initial trial involves participants aged 60 and over and is taking place at the National Institute for Health Research Manchester Clinical Research Facility (NIHR MCRF) at Manchester Royal Infirmary, part of Manchester University NHS Foundation Trust (MFT).
GRT-R910, the creators of the drug, hope it can boost the immune response of first-generation Covid-19 vaccines to a wide array of variants of Sars-Cov-2, which cause Covid-19. READ MORE: DWP are checking your bank